Diabetes Drug Metformin May Reduce Long COVID Risk
The odds of developing long COVID were lowered by about 40 percent in COVID-19 patients who received metformin, a new study found.
Stay updated with breaking news from John Buse. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The odds of developing long COVID were lowered by about 40 percent in COVID-19 patients who received metformin, a new study found.
Center for Biological Diversity: L.A. County Ordered to Set Aside Approvals for Risky Sprawl Development
A new generation of breakthrough drugs promises to revolutionize the treatment of obesity. But there are concerns.
An artificial pancreas has long been considered the holy grail for people with Type 1 diabetes, and new research suggests a more convenient version of this technology may help the millions of people living with Type 2 diabetes.
New research suggests a more convenient version of this technology may help the millions of people living with type 2 diabetes, not just type 1.